Mediantechn Asset Resilience Ratio
Mediantechn asset resilience ratio. Mediantechn (ALMDT) has an Asset Resilience Ratio of 0.45% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Mediantechn defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Mediantechn (2008–2025)
Asset resilience ratio of Mediantechn from 2008 to 2025. This chart shows how Mediantechn's Asset Resilience Ratio has changed over time. Read Mediantechn (ALMDT) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Mediantechn's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Mediantechn (ALMDT) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €163.00K | 0.45% |
| Total Liquid Assets | €163.00K | 0.45% |
Asset Resilience Insights
- Limited Liquidity: Mediantechn maintains only 0.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Mediantechn Industry Peers by Asset Resilience Ratio
Compare Mediantechn's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 26.03% |
|
Paxman AB
ST:PAX |
Medical Devices | -3.83% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd
TA:PULS |
Medical Devices | 51.61% |
|
Geratherm Medical AG
XETRA:GME |
Medical Devices | 34.89% |
Mediantechn Asset Resilience Ratio by Year (2008–2025)
Mediantechn asset resilience ratio by year from 2008 to 2025. The table below shows the annual Asset Resilience Ratio data for Mediantechn.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.45% | €163.00K ≈ $190.56K |
€35.87 Million ≈ $41.94 Million |
-0.17pp |
| 2024-12-31 | 0.62% | €151.00K ≈ $176.53K |
€24.37 Million ≈ $28.49 Million |
+0.28pp |
| 2023-12-31 | 0.34% | €123.00K ≈ $143.80K |
€35.94 Million ≈ $42.01 Million |
-0.23pp |
| 2022-12-31 | 0.58% | €200.00K ≈ $233.82K |
€34.75 Million ≈ $40.63 Million |
-78.90pp |
| 2021-12-31 | 79.47% | €39.25 Million ≈ $45.89 Million |
€49.39 Million ≈ $57.74 Million |
+14.62pp |
| 2020-12-31 | 64.86% | €16.40 Million ≈ $19.17 Million |
€25.28 Million ≈ $29.56 Million |
+63.98pp |
| 2019-12-31 | 0.87% | €141.00K ≈ $164.84K |
€16.12 Million ≈ $18.85 Million |
+0.36pp |
| 2018-12-31 | 0.52% | €94.00K ≈ $109.90K |
€18.15 Million ≈ $21.22 Million |
-0.09pp |
| 2017-12-31 | 0.60% | €206.00K ≈ $240.84K |
€34.14 Million ≈ $39.92 Million |
+0.34pp |
| 2016-12-31 | 0.26% | €123.00K ≈ $143.80K |
€46.55 Million ≈ $54.43 Million |
-0.01pp |
| 2015-12-31 | 0.27% | €91.00K ≈ $106.39K |
€33.55 Million ≈ $39.22 Million |
-0.05pp |
| 2014-12-31 | 0.32% | €58.00K ≈ $67.81K |
€17.87 Million ≈ $20.89 Million |
-10.31pp |
| 2011-12-31 | 10.64% | €1.11 Million ≈ $1.30 Million |
€10.47 Million ≈ $12.24 Million |
-49.54pp |
| 2010-12-31 | 60.17% | €2.81 Million ≈ $3.28 Million |
€4.67 Million ≈ $5.46 Million |
+6.27pp |
| 2009-12-31 | 53.90% | €2.71 Million ≈ $3.16 Million |
€5.02 Million ≈ $5.87 Million |
+29.99pp |
| 2008-12-31 | 23.92% | €1.39 Million ≈ $1.63 Million |
€5.83 Million ≈ $6.81 Million |
-- |
About Mediantechn
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnos… Read more